Dirk Hasenclever

14.3k citations
128 papers · 5.9k indexed · 2 hit papers · h-index 41

Impact in

Papers in

Dirk Hasenclever

124 papers receiving 5.8k citations

Hit Papers

Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease 2003 · 538 citations
5382002202620102018250500750

Peers

Dirk Hasenclever
Comparison fields: 5 of 126
  • Pathology and Forensic Medicine 3.9k
  • Neurology 1.5k
  • Genetics 1.0k
  • Oncology 2.5k
  • Hematology 628
Replace Carol S. Portlock with:
Carol S. Portlock United States
David J. Straus United States
Cheolwon Suh South Korea
Maurice Tubiana France
Richard Tsang Canada
Félix Reyes France
Jan Walewski Poland
Patrice Carde France
Sherrie L. Perkins United States
Michael Crump Canada
Dirk Hasenclever relative to Carol S. Portlock United States Carol S. Portlock's profile →
Citations per field
00.5×1.5×2.2×
Carol S. Portlock · 1×
Citations per year

Countries citing papers authored by Dirk Hasenclever

Since Specialization
Citations

This map shows the geographic impact of Dirk Hasenclever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Hasenclever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Hasenclever more than expected).

Fields of papers citing papers by Dirk Hasenclever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Hasenclever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Hasenclever. The network helps show where Dirk Hasenclever may publish in the future.

Co-authors

The 25 scholars most cited alongside Dirk Hasenclever, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dirk Hasenclever Line = papers co-authored together Dirk Hasenclever links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 20243
3 20231
4 20233
5 20208
6 20205
7
Ace Inhibitor For Lung Protection During Mechanical Ventilation For Acute Lung Injury-Results Of The Double-Blind, Placebo Controlled, Randomised Acemevent Pilot Study
20174
8 201711
9 20155
10 20142
11 20104
12 2009303
13 200922
14 200869
15 200816
16 20053
17 199810
18 1998201
19 1997104
20 199495

About Dirk Hasenclever

Dirk Hasenclever is a scholar working on Pathology and Forensic Medicine, Genetics, Pulmonary and Respiratory Medicine, Hematology and Oncology, having authored 128 papers that have together received 5.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (67 papers), Lung Cancer Treatments and Mutations (33 papers), Medical Imaging Techniques and Applications (13 papers), Chronic Lymphocytic Leukemia Research (11 papers), Viral-associated cancers and disorders (9 papers), Acute Lymphoblastic Leukemia research (9 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.9k citations), Neurology (1.5k citations), Genetics (1.0k citations), Oncology (2.5k citations) and Hematology (628 citations). Dirk Hasenclever has collaborated with scholars based in Germany, United Kingdom and France. Frequent co-authors include Volker Diehl, Markus Loeffler, Michael Pfreundschuh, Norbert Schmitz, Jeremy Franklin, M. Sextro, Hans Tesch, Markus Sieber, Richard Herrmann and B. Lathan. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Blood, PLoS ONE and Annals of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026